Synopsys (SNPS) Tops Q4 EPS by 6c, Offers Guidance

Synopsys (NASDAQ: SNPS) reported Q4 EPS of $1.91, $0.06 better than the analyst estimate of $1.85. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion.

GUIDANCE:

Synopsys sees Q1 2023 EPS of $2.48-$2.53, versus the consensus of $2.29. Synopsys sees Q1 2023 revenue of $1.34-1.37 billion, versus the consensus of $1.34 billion.

Synopsys sees FY2023 EPS of $10.28-$10.35, versus the consensus of $10.08. Synopsys sees FY2023 revenue of $5.78-5.83 billion, versus the consensus of $5.68 billion.

For earnings history and earnings-related data on Synopsys (SNPS) click here.

You May Also Be Interested In

• Regeneron shares rise as eczema drug sales help drugmaker post Q4 earnings beat
• Gilead Sciences shares gain after topping expectations despite lower remdesivir sales
• Ubiquiti (UI) Tops Q2 EPS by 33c